Novavax

(NASDAQ) NVAX

Current Price$9.07

Market Cap$1.54B

Since IPO (1995)-88%

5 Year-93%

1 Year+57%

1 Month+11%

Novavax Financials at a Glance

Market Cap

$1.54B

Revenue (TTM)

$596.34M

Net Income (TTM)

$87.83M

EPS (TTM)

$-0.60

P/E Ratio

-15.65

Dividend

$0.00

Beta (Volatility)

1.81 (High)

Dividend

$0.00

Beta (Volatility)

1.81 (High)

Price

$9.07

Volume

119,197

Open

$9.20

Price

$9.07

Volume

119,197

Open

$9.20

Previous Close

$9.07

Daily Range

$8.93 - $9.32

52-Week Range

$6.13 - $11.97

Dividend

$0.00

Beta (Volatility)

1.81 (High)

Price

$9.07

Volume

119,197

Open

$9.20

Previous Close

$9.07

Daily Range

$8.93 - $9.32

52-Week Range

$6.13 - $11.97

NVAX News

vaccine COVID coronavirus pandemic health(3)

Page 1

NVAX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novavax

Industry

Biotechnology

Sector

Health Care

Employees

749

CEO

John C.s Jacobs, MBA

Website

www.novavax.com

Headquarters

Gaithersburg, MD 20878, US

NVAX Financials

Key Financial Metrics (TTM)

Gross Margin

85%

Operating Margin

-11%

Net Income Margin

-15%

Return on Equity

Return on Capital

-10%

Return on Assets

-8%

Earnings Yield

-6.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.54B

Shares Outstanding

164.44M

Volume

119.20K

Avg. Volume

4.66M

Financials (TTM)

Gross Profit

$1.05B

Operating Income

$563.27M

EBITDA

$492.33M

Operating Cash Flow

$244.63M

Capital Expenditure

$5.56M

Free Cash Flow

$250.19M

Cash & ST Invst.

$735.08M

Total Debt

$248.81M

Novavax Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$139.51M

-79.1%

Gross Profit

$108.82M

-83.3%

Gross Margin

78.00%

N/A

Market Cap

$1.54B

N/A

Market Cap/Employee

$1.62M

N/A

Employees

952

N/A

Net Income

$9.49M

-101.8%

EBITDA

$15.43M

-102.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$495.27M

-1.5%

Accounts Receivable

$23.31M

-47.6%

Inventory

$11.46M

+11.6%

Long Term Debt

$292.95M

+31.3%

Short Term Debt

$2.11M

-61.4%

Return on Assets

-8.42%

N/A

Return on Invested Capital

-9.53%

N/A

Free Cash Flow

$33.69M

+82.0%

Operating Cash Flow

$32.42M

+82.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$13.67+4.43%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$70.62-4.99%

PGENPrecigen, Inc.

PGENPrecigen, Inc.$4.42-3.91%

WVEWave Life Sciences Ltd.

WVEWave Life Sciences Ltd.$6.77-1.88%

TRVITrevi Therapeutics, Inc.

TRVITrevi Therapeutics, Inc.$14.20-5.84%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

ORICORIC Pharmaceuticals, Inc.

ORICORIC Pharmaceuticals, Inc.$8.15-2.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.61-0.05%

NOKNokia

NOKNokia$13.96-0.03%

FFord Motor Company

FFord Motor Company$13.44-0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.82-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.19-0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.72+0.04%

PIIIP3 Health Partners

PIIIP3 Health Partners$12.88+2.20%

Questions About NVAX

What is the current price of Novavax?

Novavax is trading at $9.08 per share.

What is the 52-week range for Novavax?

Over the past 52 weeks, Novavax has traded between $6.13 and $11.97.

How much debt does Novavax have?

As of the most recent reporting period, Novavax reported total debt of $295.06M.

How much cash does Novavax have on hand?

Novavax reported $228.36M in cash and cash equivalents in its most recent financial results.

What is Novavax’s dividend yield?

Novavax does not currently have a dividend yield.

Novavax

Novavax Financials at a Glance

NVAX News

This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?

Why I Wouldn't Touch Novavax With a 10-Foot Pole

Novavax (NVAX) Profit Jumps on Milestone

This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?

How Bad Is This News for Novavax?

Should You Buy Novavax Stock After This Regulatory Win?

Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?

Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?

NVAX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novavax

NVAX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novavax Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVAX

What is the current price of Novavax?

What is the 52-week range for Novavax?

How much debt does Novavax have?

How much cash does Novavax have on hand?

What is Novavax’s dividend yield?

Premium Investing Services